In Vitro Identification and Characteristics of CD34- Leukemia Stem Cell in t(8;21) Acute Myeloid Leukemia

Zhongguo shi yan xue ye xue za zhi
Yan-Huan ZhangYa-Zhen Qin

Abstract

To preliminarily identify the existence of CD34- leukemia stem cell (LSC) in t(8;21) acute myeloid leukemia (AML) by in vitro test. Bone marrow samples collected from newly diagnosed t(8;21) AML patients were tested. Lin-CD34+ CD38-(abbreviation, CD34+CD38-), Lin-CD34+CD38+ (abbreviation, CD34+CD38+) and Lin-CD34-CD38-CD45dimSSClow(abbreviation, CD34-"LSC") cell fractions were gated by flow cytometry after staining with fluorescent antibodies. Cells in G0 phase were identified through Hoechst 33342 and pyronin Y staining. Aldefluor reagent was used to test aldehyde dehydrogenase (ALDH) activity. The above-mentioned 3 cell fractions were sorted, and mRNA levels of AML1-ETO and WT1 were measured by real-time quantitative PCR. The 3 tested samples displayed the same tendency in ratio of the cells in G0 phase: CD34-"LSC">CD34+ CD38->CD34+CD38+. The paired t-test of 53 patients showed that frequency of ALDHbr cells of both CD34+CD38- and CD34-"LSC" cell fractions was significantly higher than that of CD34+CD38+ (P<0.01), furthermore, the ALDHbr cell frequency was significantly higher in CD34-"LSC" than that in CD34+ CD38- (P<0.01). AML1-ETO mRNA levels of cells sorted from 3 patients were similar among the 3 cell fractions within ea...Continue Reading

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.